00000000|MMI|16.10|Musculoskeletal Pain|C0026858|[fndg]|["MUSCULOSKELETAL PAIN"-tx-1-"Musculoskeletal pain"-noun-0]|TX|65/20|C05.651.538;C10.597.617.231;C23.888.592.612.547;F02.830.816.353;G11.561.600.810.353
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|122/13|
00000000|MMI|3.59|20%|C3842589|[fndg]|["20%"-tx-1-"20"-fraction-0]|TX|43/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.46|1+|C3816745|[fndg]|["1+"-tx-1-"1"-fraction-0]|TX|112/1|
00000000|MMI|3.46|1+ Score|C2827734|[qnco]|["1+"-tx-1-"1"-fraction-0]|TX|112/1|
00000000|MMI|3.46|1+ Score, WHO|C2981698|[clas]|["1+"-tx-1-"1"-fraction-0]|TX|112/1|
00000000|MMI|3.46|30%|C3842588|[fndg]|["30%"-tx-1-"30"-fraction-0]|TX|114/2|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|90/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|90/3|
00000000|MMI|19.45|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|39/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Order (action)|C1705178|[acty]|["Order"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|Order (arrangement)|C1705176|[qlco]|["Order"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|Order (document)|C1705175|[inpr]|["Order"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|Order (taxonomic)|C1705177|[clas]|["Order"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|Permutation|C1882348|[qlco]|["Order"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|5.18|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-1-"ORDERS"-verb-0]|TX|49/6|
00000000|MMI|3.68|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|39/9|
00000000|MMI|3.68|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|39/9|
00000000|MMI|3.63|1+|C3816745|[fndg]|["1+"-tx-1-"1"-fraction-0]|TX|16/1|
00000000|MMI|3.63|1+ Score|C2827734|[qnco]|["1+"-tx-1-"1"-fraction-0]|TX|16/1|
00000000|MMI|3.63|1+ Score, WHO|C2981698|[clas]|["1+"-tx-1-"1"-fraction-0]|TX|16/1|
00000000|MMI|3.63|29+|C3843708|[fndg]|["29+"-tx-1-"29"-fraction-0]|TX|18/2|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|151.45|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-22-"ASA"-noun-0,"ASA"-tx-15-"ASA"-noun-0,"ASPIRIN"-tx-5-"ASPIRIN"-noun-0,"ASPIRIN"-tx-4-"ASPIRIN"-noun-0]|TX|3143/3;2682/3;770/7;[451/7],[568/7]|D02.455.426.559.389.657.410.595.176
00000000|MMI|128.17|Portugal|C0032729|[geoa]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[963/2],[1122/2],[1224/2],[1327/2],[1420/2];[714/2],[848/2];[395/2],[599/2];282/2|Z01.542.727
00000000|MMI|104.71|Dominican Republic|C0013014|[geoa]|["DR"-tx-48-"Dr"-noun-0,"DR"-tx-42-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0]|TX|4972/2;4680/2;4607/2;2442/2;1651/2;1605/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|101.68|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharged"-tx-27-"discharged"-verb-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5179/9;4742/9;3627/10;1740/9;13/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|84.32|Physicians|C0031831|[prog]|["DR"-tx-48-"Dr"-noun-0,"DR"-tx-42-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0]|TX|4972/2;4680/2;4607/2;2442/2;1651/2;1605/2|M01.526.485.810;N02.360.810
00000000|MMI|83.79|Rabbi|C0684010|[prog]|["R."-tx-27-"r"-adj-0,"R."-tx-20-"R"-adj-0,"R."-tx-19-"R"-adj-0,"R."-tx-17-"R"-adj-0,"R."-tx-9-"R"-noun-0,"R."-tx-8-"r"-adj-0]|TX|3614/1;3035/1;2861/1;2814/1;2232/1;1723/1|M01.526.799.500
00000000|MMI|68.19|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-6-"WARFARIN"-noun-0,"WARFARIN"-tx-5-"WARFARIN"-noun-0,"WARFARIN"-tx-4-"WARFARIN"-noun-0]|TX|1046/8;784/8;465/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|68.19|Warfarin Sodium|C0376218|[hops,orch,phsu]|["WARFARIN SODIUM"-tx-6-"WARFARIN SODIUM"-noun-0,"WARFARIN SODIUM"-tx-5-"WARFARIN SODIUM"-noun-0,"WARFARIN SODIUM"-tx-4-"WARFARIN SODIUM"-noun-0]|TX|947/15;698/15;379/15|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|67.91|Mongolia|C0026410|[geoa]|["MG"-tx-6-"MG"-noun-0,"MG"-tx-5-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0]|TX|[1141/2],[1215/2],[1324/2];845/2;596/2|Z01.252.474.651
00000000|MMI|59.06|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-51-"INR"-noun-0,"INR"-tx-34-"INR"-noun-0,"INR"-tx-33-"INR"-noun-0]|TX|4998/3;4210/3;4132/3|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|56.89|Override|C1547671|[acty]|["Override"-tx-6-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-4-"override"-verb-0,"Override"-tx-3-"Override"-verb-0]|TX|1066/8;[857/8],[874/8];804/8;[608/8],[625/8];485/8;[289/8],[306/8]|
00000000|MMI|54.24|Togo|C0040363|[geoa]|["TO"-tx-35-"to"-adv-0,"TO"-tx-30-"to"-adv-0,"TO"-tx-24-"to"-adv-0]|TX|4233/2;3903/2;3340/2|Z01.058.290.190.800
00000000|MMI|54.24|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-35-"to"-adv-0,"TO"-tx-30-"to"-adv-0,"TO"-tx-24-"to"-adv-0]|TX|4233/2;3903/2;3340/2|D08.811.520.224.800
00000000|MMI|51.38|Outpatients|C0029921|[podg]|["Outpatient"-tx-47-"outpatient"-noun-0,"Outpatient"-tx-45-"outpatient"-noun-0,"Outpatient"-tx-30-"outpatient"-noun-0,"Outpatient"-tx-27-"outpatient"-noun-0,"Outpatient"-tx-24-"outpatient"-noun-0]|TX|4829/10;4803/10;3993/10;3660/10;3329/10|M01.643.630
00000000|MMI|49.67|Lesotho|C0023376|[geoa]|["LT"-tx-6-"lt"-noun-0]|TX|[1167/2],[1247/2],[1350/2]|Z01.058.290.175.400
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-8-"DIAGNOSIS"-noun-0]|TX|[1712/9],[1836/9]|x.x.x.x.x.x.x
00000000|MMI|45.92|Cholestyramine Resin|C0008402|[orch,phsu]|["CHOLESTYRAMINE"-tx-23-"cholestyramine"-noun-0,"Cholestyramine Resin"-tx-6-"CHOLESTYRAMINE RESIN"-noun-0]|TX|3248/14;1079/20|D05.750.716.579.159;D25.720.716.579.159;J01.637.051.720.716.579.159
00000000|MMI|45.73|Oral|C0442027|[spco]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[963/2],[1122/2],[1224/2],[1327/2],[1420/2];[714/2],[848/2];[395/2],[599/2];282/2|
00000000|MMI|45.32|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-22-"ASA"-noun-0,"ASA"-tx-15-"ASA"-noun-0]|TX|3143/3;2682/3|D08.811.277.352.827.070.250
00000000|MMI|45.10|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-51-"Coumadin"-noun-0,"Coumadin"-tx-35-"coumadin"-noun-0]|TX|5005/8;4278/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|172/4;190/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|42.15|hearing impairment|C1384666|[fndg]|["HEARING IMPAIRMENT"-tx-8-"hearing impairment"-noun-0,"HEARING LOSS"-tx-8-"hearing loss"-noun-0]|TX|2139/18;2124/12|C09.218.458.341;C10.597.751.418.341;C23.888.592.763.393.341
00000000|MMI|35.81|Hyperlipidemia|C0020473|[dsyn]|["Hyperlipidaemia, NOS"-tx-8-"hyperlipidemia"-noun-0]|TX|[1959/14],[1976/14]|C18.452.584.500.500
00000000|MMI|35.02|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-10-"HTN"-noun-0,"HTN"-tx-8-"htn"-noun-0,"HYPERTENSION"-tx-8-"hypertension"-noun-0]|TX|2336/3;1938/3;1944/12|C14.907.489
00000000|MMI|32.78|Cerebrovascular accident|C0038454|[dsyn]|["STROKE"-tx-31-"stroke"-noun-0,"CVA, NOS"-tx-10-"CVA"-noun-0]|TX|4064/6;2357/3|C10.228.140.300.775;C14.907.253.855
00000000|MMI|32.66|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-23-"Lipitor"-noun-0,"Lipitor"-tx-5-"LIPITOR"-noun-0]|TX|3233/7;817/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|32.63|Barbados|C0004739|[geoa]|["BB"-tx-32-"BB"-noun-0,"BB"-tx-22-"BB"-noun-0]|TX|4113/2;3149/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|32.29|Pain|C0030193|[sosy]|["PAIN"-tx-39-"pain"-noun-0,"pains"-tx-39-"pains"-noun-0]|TX|4396/4;4582/5|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|30.42|Aggrenox|C0732282|[orch,phsu]|["Aggrenox"-tx-3-"AGGRENOX"-noun-0]|TX|236/8|D02.455.426.559.389.657.410.595.176.500;D03.383.742.175.500;D26.310.125
00000000|MMI|30.42|Aspirin / Dipyridamole|C0732279|[phsu]|["ASPIRIN/DIPYRIDAMOLE"-tx-3-"ASPIRIN DIPYRIDAMOLE"-noun-0]|TX|247/7,257/12|D02.455.426.559.389.657.410.595.176.500;D03.383.742.175.500;D26.310.125
00000000|MMI|29.69|Daily|C0332173|[tmco]|["/day"-tx-34-"day"-noun-0,"Daily"-tx-6-"DAILY"-adj-0,"Daily"-tx-6-"DAILY"-adv-0,"Daily"-tx-5-"DAILY"-adj-0,"Daily"-tx-4-"DAILY"-adj-0]|TX|4204/3;[1147/5],[1227/5],[1330/5],[1398/5];[1147/5],[1227/5],[1330/5],[1398/5];851/5;602/5|
00000000|MMI|29.46|Costa Rica|C0010182|[geoa]|["CRI"-tx-10-"CRI"-noun-0,"CRI"-tx-8-"CRI"-noun-0]|TX|2379/3;2053/3|Z01.107.169.238
00000000|MMI|27.70|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-48-"Follow up"-adj-0,"FOLLOW-UP"-tx-43-"follow up"-adj-0,"FOLLOW-UP"-tx-42-"Follow up"-adj-0,"FOLLOW-UP"-tx-39-"Follow up"-adj-0,"FOLLOW-UP"-tx-27-"follow up"-adj-0,"FOLLOW-UP"-tx-8-"follow up"-adj-0,"FOLLOW-UP"-tx-6-"FOLLOW UP"-adj-0]|TX|4935/9;4713/9;4667/9;4594/9;3671/9;1681/9;1554/9|
00000000|MMI|27.70|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-48-"Follow up"-adj-0,"Follow-Up"-tx-43-"follow up"-adj-0,"Follow-Up"-tx-42-"Follow up"-adj-0,"Follow-Up"-tx-39-"Follow up"-adj-0,"Follow-Up"-tx-27-"follow up"-adj-0,"Follow-Up"-tx-8-"follow up"-adj-0,"Follow-Up"-tx-6-"FOLLOW UP"-adj-0]|TX|4935/9;4713/9;4667/9;4594/9;3671/9;1681/9;1554/9|
00000000|MMI|27.70|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-48-"Follow up"-adj-0,"Follow-up"-tx-43-"follow up"-adj-0,"Follow-up"-tx-42-"Follow up"-adj-0,"Follow-up"-tx-39-"Follow up"-adj-0,"Follow-up"-tx-27-"follow up"-adj-0,"Follow-up"-tx-8-"follow up"-adj-0,"Follow-up"-tx-6-"FOLLOW UP"-adj-0]|TX|4935/9;4713/9;4667/9;4594/9;3671/9;1681/9;1554/9|
00000000|MMI|27.70|follow-up|C1522577|[hlca]|["Follow Up"-tx-48-"Follow up"-adj-0,"Follow Up"-tx-43-"follow up"-adj-0,"Follow Up"-tx-42-"Follow up"-adj-0,"Follow Up"-tx-39-"Follow up"-adj-0,"Follow Up"-tx-27-"follow up"-adj-0,"Follow Up"-tx-8-"follow up"-adj-0,"Follow Up"-tx-6-"FOLLOW UP"-adj-0]|TX|4935/9;4713/9;4667/9;4594/9;3671/9;1681/9;1554/9|
00000000|MMI|27.22|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-51-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|5124/3;921/3;672/3;353/3;167/3|
00000000|MMI|26.39|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-39-"shortness of breath"-noun-0,"SOB"-tx-12-"SOB"-noun-0]|TX|4501/19;2549/3|C08.618.326;C23.888.852.371
00000000|MMI|26.26|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-31-"Afib"-noun-0,"AFib"-tx-10-"Afib"-noun-0]|TX|4033/4;2372/4|C14.280.067.198;C23.550.073.198
00000000|MMI|26.14|Panama|C0030266|[geoa]|["PM"-tx-53-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5162/2;52/2|Z01.107.169.772
00000000|MMI|24.11|Deafness|C0011053|[fndg]|["hearing loss"-tx-8-"hearing loss"-noun-0]|TX|2124/12|C09.218.458.341.186;C10.597.751.418.341.186;C23.888.592.763.393.341.186
00000000|MMI|24.11|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-22-"STATIN"-noun-0]|TX|3154/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|24.11|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-6-"INSULIN GLARGINE"-noun-0]|TX|1367/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2160/10|x.x.x.x.x.x.x
00000000|MMI|23.16|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-48-"Dr"-noun-0,"DR"-tx-42-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0]|TX|4972/2;4680/2;4607/2;2442/2;1651/2;1605/2|
00000000|MMI|23.16|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-48-"Dr"-noun-0,"DR"-tx-42-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0]|TX|4972/2;4680/2;4607/2;2442/2;1651/2;1605/2|
00000000|MMI|23.16|Doctor - Title|C2348314|[cnce]|["Dr."-tx-48-"Dr"-noun-0,"Dr."-tx-42-"Dr"-noun-0,"Dr."-tx-39-"Dr"-noun-0,"Dr."-tx-10-"Dr"-noun-0,"Dr."-tx-7-"Dr"-noun-0,"Dr."-tx-6-"Dr"-noun-0]|TX|4972/2;4680/2;4607/2;2442/2;1651/2;1605/2|
00000000|MMI|22.68|risk factors|C0035648|[qnco]|["Risk Factors"-tx-20-"risk factors"-noun-0]|TX|2967/12|E05.318.740.600.800.725;N05.715.350.200.700;N05.715.360.750.625.700.700;N06.850.490.625.750;N06.850.520.830.600.800.725
00000000|MMI|22.63|R prime|C2603358|[clna]|["R'"-tx-27-"r"-adj-0,"R'"-tx-20-"R"-adj-0,"R'"-tx-19-"R"-adj-0,"R'"-tx-17-"R"-adj-0,"R'"-tx-9-"R"-noun-0,"R'"-tx-8-"r"-adj-0]|TX|3614/1;3035/1;2861/1;2814/1;2232/1;1723/1|
00000000|MMI|22.63|Right|C0205090|[spco]|["R-"-tx-27-"r"-adj-0,"R-"-tx-20-"R"-adj-0,"R-"-tx-19-"R"-adj-0,"R-"-tx-17-"R"-adj-0,"R-"-tx-9-"R"-noun-0,"R-"-tx-8-"r"-adj-0]|TX|3614/1;3035/1;2861/1;2814/1;2232/1;1723/1|
00000000|MMI|22.61|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-6-"LANTUS"-noun-0]|TX|1358/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|22.50|Risk Assessment|C0086930|[hlca]|["Risk Assessment"-tx-30-"risk assessment"-noun-0]|TX|3974/15|E05.318.740.600.800.715;N04.452.871.715;N05.715.360.750.625.700.690;N06.850.505.715;N06.850.520.830.600.800.715
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|x.x.x.x.x.x.x
00000000|MMI|22.38|Losartan|C0126174|[orch,phsu]|["LOSARTAN"-tx-6-"LOSARTAN"-noun-0]|TX|1203/8|D02.455.426.559.389.185.475;D03.383.129.308.507;D03.383.129.617.467
00000000|MMI|21.36|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-52-"PH.D"-noun-0,"Ph.D."-tx-6-"PH.D"-noun-0,"Ph.D."-tx-5-"PH.D"-noun-0,"Ph.D."-tx-4-"PH.D"-noun-0]|TX|5131/4;928/4;679/4;360/4|
00000000|MMI|21.36|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-51-"Note"-noun-0,"Note"-tx-29-"note"-verb-0,"Note"-tx-25-"note"-noun-0,"Note"-tx-21-"Note"-noun-0]|TX|5023/4;3789/4;3370/4;3040/4|
00000000|MMI|21.36|Hold (action)|C1948035|[acty]|["Hold"-tx-35-"hold"-verb-0,"Hold"-tx-6-"HOLD"-verb-0]|TX|4236/4;[1153/4],[1233/4],[1336/4]|
00000000|MMI|21.36|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-35-"hold"-verb-0,"Hold"-tx-6-"HOLD"-verb-0]|TX|4236/4;[1153/4],[1233/4],[1336/4]|
00000000|MMI|21.36|Note (document)|C1317574|[inpr]|["Note"-tx-51-"Note"-noun-0,"Note"-tx-29-"note"-verb-0,"Note"-tx-25-"note"-noun-0,"Note"-tx-21-"Note"-noun-0]|TX|5023/4;3789/4;3370/4;3040/4|
00000000|MMI|21.36|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-35-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-25-"Pt"-noun-0,"PT"-tx-21-"Pt"-noun-0]|TX|4219/2;3620/2;3377/2;3047/2|
00000000|MMI|21.36|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-35-"Pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-25-"Pt"-noun-0,"PT"-tx-21-"Pt"-noun-0]|TX|4219/2;3620/2;3377/2;3047/2|
00000000|MMI|21.36|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-35-"hold"-verb-0,"hold"-tx-6-"HOLD"-verb-0]|TX|4236/4;[1153/4],[1233/4],[1336/4]|
00000000|MMI|20.95|Hearing Loss|C3887873|[fndg]|["Hearing Loss"-tx-8-"hearing loss"-noun-0]|TX|2124/12|C09.218.458.341;C10.597.751.418.341;C23.888.592.763.393.341
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-44-"CONDITION"-noun-0,"condition"-tx-8-"Conditions"-noun-0]|TX|4752/9;1846/10|C23.550.288
00000000|MMI|19.93|Stent, device|C0038257|[medd]|["stenting"-tx-10-"stenting"-noun-0,"Stent"-tx-8-"stent"-noun-0]|TX|2400/8;2019/5|E07.695.750
00000000|MMI|19.72|Ambulatory Care Facilities|C0002424|[hcro,mnob]|["Clinic"-tx-51-"Clinic"-noun-0,"Clinic"-tx-35-"clinic"-noun-0]|TX|5014/6;4287/6|N02.278.035
00000000|MMI|19.38|Hypertrophic Cardiomyopathy|C0007194|[dsyn]|["Cardiomyopathy, Hypertrophic"-tx-30-"hypertrophic cardiomyopathy"-noun-0]|TX|3926/27|C14.280.238.100;C14.280.484.150.070.160
00000000|MMI|19.36|Lopressor|C0700776|[orch,phsu]|["Lopressor"-tx-26-"lopressor"-noun-0]|TX|3451/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|91/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.24|Gastric ulcer|C0038358|[dsyn]|["GASTRIC ULCER"-tx-8-"gastric ulcer"-noun-0]|TX|1993/13|C06.405.469.275.800.849;C06.405.748.586.849
00000000|MMI|19.22|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-6-"ATENOLOL"-noun-0]|TX|1429/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|19.02|Order (action)|C1705178|[acty]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|19.02|Order (arrangement)|C1705176|[qlco]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|19.02|Order (document)|C1705175|[inpr]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|19.02|Order (taxonomic)|C1705177|[clas]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|19.02|Permutation|C1882348|[qlco]|["Order"-tx-53-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|19.02|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-53-"ORDERS"-verb-0,"ORDER"-tx-6-"order"-noun-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-4-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0]|TX|5189/6;937/5;688/5;369/5;95/5|
00000000|MMI|18.56|Home environment|C0442519|[cnce]|["house"-tx-32-"house"-adj-0,"HOME"-tx-26-"home"-noun-0,"house"-tx-22-"house"-adj-0,"house"-tx-6-"House"-noun-0,"HOME"-tx-3-"Home"-noun-0]|TX|4104/5;3500/4;3122/5;1459/5;208/4|
00000000|MMI|18.24|Patient Class - Outpatient|C1549405|[clas]|["Outpatient"-tx-47-"outpatient"-noun-0,"Outpatient"-tx-45-"outpatient"-noun-0,"Outpatient"-tx-30-"outpatient"-noun-0,"Outpatient"-tx-27-"outpatient"-noun-0,"Outpatient"-tx-24-"outpatient"-noun-0]|TX|4829/10;4803/10;3993/10;3660/10;3329/10|
00000000|MMI|18.24|Referral category - Outpatient|C1548439|[idcn]|["Outpatient"-tx-47-"outpatient"-noun-0,"Outpatient"-tx-45-"outpatient"-noun-0,"Outpatient"-tx-30-"outpatient"-noun-0,"Outpatient"-tx-27-"outpatient"-noun-0,"Outpatient"-tx-24-"outpatient"-noun-0]|TX|4829/10;4803/10;3993/10;3660/10;3329/10|
00000000|MMI|18.20|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-5-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0]|TX|[1141/2],[1215/2],[1324/2];845/2;596/2|
00000000|MMI|18.20|Milligram percent|C1960952|[qnco]|["mg %"-tx-6-"MG"-noun-0,"mg %"-tx-5-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0]|TX|[1141/2],[1215/2],[1324/2];845/2;596/2|
00000000|MMI|18.20|mg/dL|C0439269|[qnco]|["mg%"-tx-6-"MG"-noun-0,"mg%"-tx-5-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0]|TX|[1141/2],[1215/2],[1324/2];845/2;596/2|
00000000|MMI|17.80|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-8-"coronary artery disease"-noun-0]|TX|2027/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-8-"coronary artery disease"-noun-0]|TX|2027/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-29-"EKG"-noun-0]|TX|3799/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|17.80|Electrocardiography|C1623258|[diap]|["EKG"-tx-29-"EKG"-noun-0]|TX|3799/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|17.80|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-6-"LISINOPRIL"-noun-0]|TX|1308/10|D12.644.456.345.600
00000000|MMI|17.80|Musculoskeletal Pain|C0026858|[fndg]|["MUSCULOSKELETAL PAIN"-tx-8-"Musculoskeletal pain"-noun-0]|TX|1809/20|C05.651.538;C10.597.617.231;C23.888.592.612.547;F02.830.816.353;G11.561.600.810.353
00000000|MMI|16.37|Renal Insufficiency|C1565489|[dsyn]|["Renal dysfunction"-tx-8-"renal dysfunction"-noun-0]|TX|2067/17|C12.777.419.780;C13.351.968.419.780
00000000|MMI|16.34|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-6-"Low fat DIET"-noun-0]|TX|1467/3,1485/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.30|Zestril|C0678140|[aapp,phsu]|["Zestril"-tx-6-"ZESTRIL"-noun-0]|TX|1298/7|D12.644.456.345.600
00000000|MMI|16.21|Exercise stress test|C0015260|[diap]|["stress test"-tx-21-"stress test"-noun-0]|TX|3075/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|16.21|Stress Test|C3494508|[diap]|["Stress Test"-tx-21-"stress test"-noun-0]|TX|3075/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|16.18|Fluorides|C0016327|[inch,phsu]|["F-"-tx-10-"f"-noun-0]|TX|2435/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|16.18|Motrin|C0699203|[orch,phsu]|["Motrin"-tx-39-"motrin"-noun-0]|TX|4560/6|D02.241.223.701.430
00000000|MMI|16.15|Atorvastatin calcium|C0286650|[orch,phsu]|["ATORVASTATIN CALCIUM"-tx-6-"ATORVASTATIN CALCIUM"-noun-0]|TX|1019/20|D03.383.129.578.075;D10.251.450.200
00000000|MMI|16.07|Doxazosin|C0114873|[orch,phsu]|["DOXAZOSIN"-tx-6-"DOXAZOSIN"-noun-0]|TX|1129/9|D03.438.786.750.200
00000000|MMI|16.06|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-6-"GLYBURIDE"-noun-0]|TX|1404/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|16.06|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-6-"SC"-noun-0]|TX|1395/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|16.05|Left Ventricular Hypertrophy|C0149721|[dsyn]|["LVH"-tx-29-"LVH"-noun-0]|TX|3831/3|C14.280.195.400;C23.300.775.250.400
00000000|MMI|16.05|Poverty|C0032854|[grpa]|["Poor"-tx-10-"poor"-adj-0]|TX|2422/4|I01.880.735.634;I01.880.853.996.535;N01.824.600
00000000|MMI|15.79|To|C1883351|[qlco]|["To"-tx-35-"to"-adv-0,"To"-tx-30-"to"-adv-0,"To"-tx-24-"to"-adv-0]|TX|4233/2;3903/2;3340/2|
00000000|MMI|15.57|1+|C3816745|[fndg]|["1+"-tx-44-"1"-integer-0,"1+"-tx-36-"1"-integer-0,"1+"-tx-18-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|4782/1;4328/1;2836/1;272/1|
00000000|MMI|15.57|1+ Score|C2827734|[qnco]|["1+"-tx-44-"1"-integer-0,"1+"-tx-36-"1"-integer-0,"1+"-tx-18-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|4782/1;4328/1;2836/1;272/1|
00000000|MMI|15.57|1+ Score, WHO|C2981698|[clas]|["1+"-tx-44-"1"-integer-0,"1+"-tx-36-"1"-integer-0,"1+"-tx-18-"1"-integer-0,"1+"-tx-3-"1"-integer-0]|TX|4782/1;4328/1;2836/1;272/1|
00000000|MMI|15.15|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-35-"dose"-noun-0,"Dose #"-tx-26-"dose"-noun-0,"Dose number"-tx-6-"Number Doses"-noun-0,"Dose number"-tx-4-"Number Doses"-noun-0]|TX|4241/4;3566/4;1254/6,1264/5;498/6,508/5|
00000000|MMI|15.14|Clipperton Island|C4050020|[geoa]|["CP"-tx-12-"CP"-noun-0,"CP"-tx-12-"cp"-noun-0,"CP"-tx-10-"CP"-adj-0,"CP"-tx-10-"CP"-noun-0]|TX|2586/2;2530/2;[2280/2],[2459/2];[2280/2],[2459/2]|
00000000|MMI|15.09|Hospital admission|C0184666|[hlca]|["admitted"-tx-19-"Admitted"-verb-0,"Admission"-tx-17-"admission"-noun-0,"Admission"-tx-8-"Admission"-noun-0,"Admit"-tx-8-"ADMIT"-verb-0]|TX|2848/8;2785/9;1797/9;1706/5|
00000000|MMI|14.64|ACE protein, human|C1452534|[aapp,bacs]|["ACE"-tx-22-"ACE"-noun-0]|TX|3163/3|x.x.x.x
00000000|MMI|14.64|Benign Prostatic Hyperplasia|C1704272|[neop]|["BPH"-tx-8-"bph"-noun-0]|TX|2087/3|C12.294.565.500
00000000|MMI|14.64|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-8-"coronary artery disease"-noun-0]|TX|2027/23|C14.280.647.250;C14.907.585.250
00000000|MMI|14.64|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-8-"diabetes mellitus"-noun-0]|TX|1918/17|C18.452.394.750;C19.246
00000000|MMI|14.64|Ensure (product)|C0218063|[food]|["ENSURE"-tx-24-"ensure"-verb-0]|TX|3343/6|x.x.x.x
00000000|MMI|14.64|Pain-Free|C0908489|[orch]|["Pain-Free"-tx-14-"pain free"-adj-0]|TX|2665/9|x.x.x.x
00000000|MMI|14.64|Recurrence|C0034897|[phpr]|["recur"-tx-39-"recur"-verb-0]|TX|4401/5|C23.550.291.937
00000000|MMI|14.52|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-24-"DM"-noun-0,"DM"-tx-20-"dm"-noun-0,"DM"-tx-10-"DM"-noun-0,"DM"-tx-8-"dm"-noun-0]|TX|3355/2;3016/2;2331/2;1913/2|
00000000|MMI|14.47|Negation|C1518422|[ftcn]|["Not"-tx-39-"not"-adv-0,"Not"-tx-20-"not"-adv-0,"Not"-tx-12-"not"-adv-0,"Not"-tx-9-"NOT"-adv-0]|TX|4415/3;2885/3;2571/3;2223/3|
00000000|MMI|14.27|Recent|C0332185|[tmco]|["Recent"-tx-31-"recent"-adj-0,"Recent"-tx-29-"recent"-adj-0,"Recent"-tx-21-"recent"-adj-0,"Recent"-tx-10-"recent"-adj-0]|TX|4057/6;3875/6;3059/6;2350/6|
00000000|MMI|13.25|Heart|C0018787|[bpoc]|["Cardiac"-tx-20-"cardiac"-adj-0,"Cardiac"-tx-10-"cardiac"-adj-0]|TX|2945/7;2427/7|A07.541
00000000|MMI|13.22|Cardiac Imaging Techniques|C2936236|[diap]|["Cardiac Imaging"-tx-47-"cardiac imaging"-adj-0]|TX|4840/15|E01.370.350.130
00000000|MMI|13.09|Electromagnetic Radiation|C0034519|[npop]|["Radiation"-tx-12-"Radiation"-noun-0]|TX|2559/9|G01.358.500.505;G01.750.250
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-44-"PLAN"-noun-0]|TX|4776/4|C10.228.140.744
00000000|MMI|13.05|Diet|C0012155|[food]|["Diet"-tx-6-"DIET"-noun-0]|TX|1453/4|G07.203.650.240
00000000|MMI|13.03|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-51-"Held"-verb-0]|TX|5030/4|x.x.x.x
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|91/3|E04.157.310;E04.950.300.299
00000000|MMI|12.96|Myocardial Infarction|C0027051|[dsyn]|["-- Heart Attack"-tx-39-"heart attack"-noun-0]|TX|4529/12|C14.280.647.500;C14.907.585.500
00000000|MMI|12.96|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-39-"PCP"-noun-0]|TX|4441/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|12.91|Gentamicin Sulfate (USP)|C0546866|[antb,orch]|["GM"-tx-6-"GM"-noun-0]|TX|1119/2|D09.408.051.374
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|9/3|J01.937.500.100
00000000|MMI|12.89|Algeria|C0002037|[geoa]|["DZ"-tx-20-"dz"-noun-0]|TX|2953/2|Z01.058.266.104
00000000|MMI|12.89|ECHO protocol|C0058928|[topp]|["ECHO"-tx-29-"echo"-noun-0]|TX|3882/4|x.x.x.x
00000000|MMI|12.89|Family|C0015576|[famg]|["Familial"-tx-30-"familial"-adj-0]|TX|3965/8|F01.829.263;I01.880.853.150
00000000|MMI|11.92|4+ Answer to question|C3838679|[fndg]|["4+"-tx-50-"4"-integer-0,"4+"-tx-41-"4"-integer-0,"4+"-tx-10-"4"-fraction-0]|TX|4986/1;4662/1;2363/1|
00000000|MMI|11.79|+2|C0740116|[qnco]|["+2"-tx-46-"2"-integer-0,"+2"-tx-38-"2"-integer-0,"+2"-tx-35-"2"-fraction-0]|TX|4815/1;4367/1;4297/1|
00000000|MMI|11.79|2+|C3833492|[fndg]|["2+"-tx-46-"2"-integer-0,"2+"-tx-38-"2"-integer-0,"2+"-tx-35-"2"-fraction-0]|TX|4815/1;4367/1;4297/1|
00000000|MMI|11.79|2+ Score|C2827735|[qnco]|["2+"-tx-46-"2"-integer-0,"2+"-tx-38-"2"-integer-0,"2+"-tx-35-"2"-fraction-0]|TX|4815/1;4367/1;4297/1|
00000000|MMI|11.79|2+ Score, WHO|C2981700|[clas]|["2+"-tx-46-"2"-integer-0,"2+"-tx-38-"2"-integer-0,"2+"-tx-35-"2"-fraction-0]|TX|4815/1;4367/1;4297/1|
00000000|MMI|11.66|Continuous|C0549178|[idcn]|["Continue"-tx-37-"Continue"-verb-0,"Continue"-tx-30-"continue"-verb-0,"Continued"-tx-22-"continued"-verb-0]|TX|4333/8;3894/8;3130/9|
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-8-"Complications"-noun-0]|TX|1872/13|x.x.x
00000000|MMI|11.49|Diagnostic Imaging|C0011923|[diap]|["Imaging"-tx-28-"imaging"-verb-0]|TX|3694/7|E01.370.350
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2175/10|x.x.x
00000000|MMI|11.49|utilization qualifier|C0042153|[ftcn]|["use"-tx-39-"use"-verb-0]|TX|4556/3|x.x.x
00000000|MMI|11.22|ALYREF gene|C1425988|[gngm]|["REF"-tx-6-"ref"-noun-0,"REF"-tx-5-"ref"-noun-0,"REF"-tx-4-"ref"-noun-0]|TX|968/3;719/3;400/3|
00000000|MMI|11.22|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-6-"lt"-noun-0]|TX|[1167/2],[1247/2],[1350/2]|
00000000|MMI|11.22|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-6-"lt"-noun-0]|TX|[1167/2],[1247/2],[1350/2]|
00000000|MMI|11.18|Followed by|C0332283|[tmco]|["follow"-tx-51-"Follow"-verb-0,"follow"-tx-35-"follow"-verb-0,"followed"-tx-24-"followed"-verb-0]|TX|4991/6;4268/6;3317/8|
00000000|MMI|11.07|Interaction|C1704675|[ftcn]|["Interaction"-tx-6-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0,"Interaction"-tx-4-"INTERACTION"-noun-0]|TX|1006/11;757/11;438/11|
00000000|MMI|11.03|Presentation|C0449450|[idcn]|["Presentation"-tx-27-"presentation"-noun-0,"Presentation"-tx-20-"presentation"-noun-0,"presentations"-tx-20-"presentations"-noun-0]|TX|3597/12;2872/12;2993/13|
00000000|MMI|11.00|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-51-"INR"-noun-0,"INR"-tx-34-"INR"-noun-0,"INR"-tx-33-"INR"-noun-0]|TX|4998/3;4210/3;4132/3|
00000000|MMI|10.98|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-27-"Given"-verb-0,"given"-tx-20-"given"-adj-0,"given"-tx-15-"Given"-adj-0]|TX|3572/5;2928/5;2676/5|
00000000|MMI|10.98|GIVEN|C1442162|[cnce]|["GIVEN"-tx-27-"Given"-verb-0,"GIVEN"-tx-20-"given"-adj-0,"GIVEN"-tx-15-"Given"-adj-0]|TX|3572/5;2928/5;2676/5|
00000000|MMI|10.98|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-27-"Given"-verb-0,"Given"-tx-20-"given"-adj-0,"Given"-tx-15-"Given"-adj-0]|TX|3572/5;2928/5;2676/5|
00000000|MMI|10.98|Given name|C3244317|[inpr]|["given"-tx-27-"Given"-verb-0,"given"-tx-20-"given"-adj-0,"given"-tx-15-"Given"-adj-0]|TX|3572/5;2928/5;2676/5|
00000000|MMI|10.96|Admission activity|C0809949|[hlca]|["Admitted"-tx-19-"Admitted"-verb-0,"Admission"-tx-17-"admission"-noun-0,"Admission"-tx-8-"Admission"-noun-0]|TX|2848/8;2785/9;1797/9|
00000000|MMI|10.96|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-51-"scheduled"-verb-0,"Scheduled"-tx-40-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0]|TX|5046/9;4651/9;1639/9|
00000000|MMI|10.96|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-51-"scheduled"-verb-0,"Scheduled"-tx-40-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0]|TX|5046/9;4651/9;1639/9|
00000000|MMI|10.96|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-51-"scheduled"-verb-0,"Scheduled"-tx-40-"scheduled"-verb-0,"Scheduled"-tx-7-"scheduled"-adj-0]|TX|5046/9;4651/9;1639/9|
00000000|MMI|10.96|Limited (extensiveness)|C0439801|[ftcn]|["Limited"-tx-47-"limited"-adj-0,"Limited"-tx-28-"limited"-verb-0,"Limited"-tx-21-"limited"-adj-0]|TX|4887/7;3773/7;3104/7|
00000000|MMI|10.96|Limited Lifting Ability|C4050251|[inpr]|["Limited"-tx-47-"limited"-adj-0,"Limited"-tx-28-"limited"-verb-0,"Limited"-tx-21-"limited"-adj-0]|TX|4887/7;3773/7;3104/7|
00000000|MMI|10.96|Limited Walking Ability|C2674459|[fndg]|["Limited"-tx-47-"limited"-adj-0,"Limited"-tx-28-"limited"-verb-0,"Limited"-tx-21-"limited"-adj-0]|TX|4887/7;3773/7;3104/7|
00000000|MMI|10.96|Limited component (foundation metadata concept)|C3542948|[inpr]|["Limited"-tx-47-"limited"-adj-0,"Limited"-tx-28-"limited"-verb-0,"Limited"-tx-21-"limited"-adj-0]|TX|4887/7;3773/7;3104/7|
00000000|MMI|10.94|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0,"Reason"-tx-4-"Reason"-noun-0]|TX|1055/6;793/6;474/6|
00000000|MMI|10.91|Room of building - Study|C0557651|[mnob]|["Study"-tx-47-"study"-noun-0,"Study"-tx-21-"study"-noun-0,"Study"-tx-8-"Study"-noun-0]|TX|4895/5;3112/5;1779/5|
00000000|MMI|10.91|Study|C2603343|[resa]|["Study"-tx-47-"study"-noun-0,"Study"-tx-21-"study"-noun-0,"Study"-tx-8-"Study"-noun-0]|TX|4895/5;3112/5;1779/5|
00000000|MMI|10.84|Additional|C1524062|[ftcn]|["Added"-tx-5-"added"-verb-0,"Added"-tx-4-"added"-verb-0,"Added"-tx-3-"added"-verb-0]|TX|883/5;634/5;315/5|
00000000|MMI|10.82|House (environment)|C2003847|[mnob]|["House"-tx-32-"house"-adj-0,"House"-tx-22-"house"-adj-0,"House"-tx-6-"House"-noun-0]|TX|4104/5;3122/5;1459/5|
00000000|MMI|10.74|80%|C3842583|[fndg]|["80%"-tx-23-"80"-integer-0,"80%"-tx-23-"80s"-noun-0,"80%"-tx-5-"80"-integer-0]|TX|3241/2;3209/3;842/2|
00000000|MMI|10.70|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0]|TX|5179/9;4742/9;1740/9|
00000000|MMI|10.70|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-53-"DISCHARGE"-noun-0,"Discharge"-tx-44-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0]|TX|5179/9;4742/9;1740/9|
00000000|MMI|10.69|Before|C0332152|[tmco]|["Prior"-tx-39-"prior"-adj-0,"Prior"-tx-28-"prior"-adj-0,"Prior"-tx-12-"prior"-adj-0]|TX|4523/5;3760/5;2580/5|
00000000|MMI|10.69|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-39-"prior"-adj-0,"PRIOR"-tx-28-"prior"-adj-0,"PRIOR"-tx-12-"prior"-adj-0]|TX|4523/5;3760/5;2580/5|
00000000|MMI|10.59|Serious|C0205404|[qlco]|["Serious"-tx-6-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0,"Serious"-tx-4-"SERIOUS"-adj-0]|TX|998/7;749/7;430/7|
00000000|MMI|10.58|Fleet|C0591516|[orch,phsu]|["fleeting"-tx-39-"fleeting"-adj-0,"fleeting"-tx-13-"fleeting"-adj-0,"fleeting"-tx-12-"fleeting"-adj-0]|TX|4375/8;2616/8;2510/8|
00000000|MMI|10.55|100%|C3817553|[qnco]|["100%"-tx-6-"100"-integer-0]|TX|[1170/3],[1250/3],[1354/3]|
00000000|MMI|10.42|Approximate|C0332232|[qlco]|["Approximate"-tx-6-"approximate"-adj-0,"Approximate"-tx-4-"approximate"-adj-0]|TX|1281/11;525/11|
00000000|MMI|10.42|Benign prostatic hypertrophy|C0005001|[patf]|["BPH"-tx-8-"bph"-noun-0,"Benign Prostatic Hypertrophy"-tx-8-"benign prostatic hypertrophy"-noun-0]|TX|2087/3;2093/28|
00000000|MMI|10.42|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-10-"CRI"-noun-0,"CRi"-tx-8-"CRI"-noun-0]|TX|2379/3;2053/3|
00000000|MMI|10.42|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-10-"CRI"-noun-0,"CRI"-tx-8-"CRI"-noun-0]|TX|2379/3;2053/3|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[1712/9],[1836/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[1712/9],[1836/9]|
00000000|MMI|10.42|RNH1 gene|C1826843|[gngm]|["CRI"-tx-10-"CRI"-noun-0,"CRI"-tx-8-"CRI"-noun-0]|TX|2379/3;2053/3|
00000000|MMI|10.42|Requirement|C1514873|[ftcn]|["Required"-tx-6-"Required"-verb-0,"Required"-tx-4-"Required"-verb-0]|TX|1270/8;514/8|
00000000|MMI|10.42|Serum lipids high (finding)|C0428465|[fndg]|["Hyperlipidemia"-tx-8-"hyperlipidemia"-noun-0]|TX|[1959/14],[1976/14]|
00000000|MMI|10.42|consider|C0750591|[idcn]|["consider"-tx-47-"Consider"-verb-0,"consider"-tx-47-"consider"-verb-0]|TX|4820/8;4903/8|
00000000|MMI|9.94|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|H02.403.044
00000000|MMI|9.91|Appointments|C0003629|[idcn]|["Appointment"-tx-6-"APPOINTMENT"-noun-0]|TX|1564/11|N04.452.095
00000000|MMI|9.90|Nasal sinus|C0030471|[bsoj]|["Sinus"-tx-31-"sinus"-noun-0]|TX|4047/5|A04.531.621
00000000|MMI|9.90|pathologic fistula|C0016169|[anab]|["Sinus"-tx-31-"sinus"-noun-0]|TX|4047/5|C23.300.575
00000000|MMI|9.89|Diet therapy|C0012159|[hlca]|["Diet"-tx-6-"DIET"-noun-0]|TX|1453/4|E02.642.249
00000000|MMI|9.87|Historical aspects qualifier|C0019665|[ftcn]|["history"-tx-20-"history"-noun-0]|TX|2934/7|x.x.x
00000000|MMI|9.78|enzymology|C0014445|[ftcn]|["enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|x.x.x
00000000|MMI|9.77|capsule (pharmacologic)|C0006935|[bodm]|["CAPSULE"-tx-3-"CAPSULE"-noun-0]|TX|274/7|D26.255.150
00000000|MMI|9.76|Ulcer|C0041582|[dsyn]|["ULCER"-tx-8-"ulcer"-noun-0]|TX|2001/5|C23.550.891
00000000|MMI|9.76|Germany|C0017480|[geoa]|["GM"-tx-6-"GM"-noun-0]|TX|1119/2|Z01.542.315;Z01.586.315
00000000|MMI|8.34|Emotions|C0013987|[menp]|["feeling"-tx-11-"feeling"-verb-0]|TX|2470/7|F01.470
00000000|MMI|8.34|Feelings|C1527305|[menp]|["Feeling"-tx-11-"feeling"-verb-0]|TX|2470/7|F01.470
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-8-"Infections"-noun-0]|TX|1859/10|C01.539
00000000|MMI|7.70|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-47-"3"-integer-0,"3+"-tx-33-"3"-real_number-0]|TX|4930/1;4140/1|
00000000|MMI|7.70|3+ Score|C2827736|[qnco]|["3+"-tx-47-"3"-integer-0,"3+"-tx-33-"3"-real_number-0]|TX|4930/1;4140/1|
00000000|MMI|7.70|3+ Score, WHO|C2981702|[clas]|["3+"-tx-47-"3"-integer-0,"3+"-tx-33-"3"-real_number-0]|TX|4930/1;4140/1|
00000000|MMI|7.70|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-47-"3"-integer-0,"<3"-tx-33-"3"-real_number-0]|TX|4930/1;4140/1|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-44-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4752/9;1846/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-44-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4752/9;1846/10|
00000000|MMI|7.61|Dosage|C0178602|[qnco]|["DOSE"-tx-35-"dose"-noun-0,"DOSE"-tx-26-"dose"-noun-0]|TX|4241/4;3566/4|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-44-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|4752/9;1846/10|
00000000|MMI|7.61|Unit dose|C0869039|[qnco]|["Dose"-tx-35-"dose"-noun-0,"Dose"-tx-26-"dose"-noun-0]|TX|4241/4;3566/4|
00000000|MMI|7.49|Follow|C1719822|[inpr]|["Follow"-tx-51-"Follow"-verb-0,"Follow"-tx-35-"follow"-verb-0]|TX|4991/6;4268/6|
00000000|MMI|7.40|Stress|C0038435|[fndg]|["Stress"-tx-47-"stress"-noun-0,"Stress"-tx-28-"stress"-noun-0]|TX|4921/6;3766/6|
00000000|MMI|7.36|Following|C0332282|[tmco]|["Following"-tx-34-"following"-adj-0,"Following"-tx-27-"following"-verb-0]|TX|4194/9;3638/9|
00000000|MMI|7.36|Status post|C0231290|[tmco]|["Following"-tx-34-"following"-adj-0,"Following"-tx-27-"following"-verb-0]|TX|4194/9;3638/9|
00000000|MMI|7.34|Episode of|C0332189|[tmco]|["Episode of"-tx-39-"episodes of"-noun-0,"Episode"-tx-13-"episode"-noun-0]|TX|4384/11;2625/7|
00000000|MMI|7.31|Asymptomatic|C0231221|[fndg]|["Asymptomatic"-tx-26-"asymptomatic"-adj-0,"Asymptomatic"-tx-25-"asymptomatic"-adj-0]|TX|3553/12;3416/12|
00000000|MMI|7.31|Respiratory Domain|C2986904|[idcn]|["RE"-tx-48-"re"-noun-0,"RE"-tx-43-"re"-noun-0]|TX|4945/2;4709/2|
00000000|MMI|7.31|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-48-"re"-noun-0,"{RE}"-tx-43-"re"-noun-0]|TX|4945/2;4709/2|
00000000|MMI|7.29|Hospital course|C0489547|[fndg]|["Hospital course"-tx-18-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-10-"HOSPITAL COURSE"-noun-0]|TX|2819/15;2259/15|
00000000|MMI|7.29|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-18-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-10-"HOSPITAL COURSE"-noun-0]|TX|2819/15;2259/15|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-51-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5086/7;120/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-51-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5086/7;120/7|
00000000|MMI|7.25|Bounded by|C0332297|[spco]|["BB"-tx-32-"BB"-noun-0,"BB"-tx-22-"BB"-noun-0]|TX|4113/2;3149/2|
00000000|MMI|7.25|Dose number|C1115464|[qnco]|["Dose number"-tx-6-"Number Doses"-noun-0,"Dose number"-tx-4-"Number Doses"-noun-0]|TX|1254/6,1264/5;498/6,508/5|
00000000|MMI|7.24|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-22-"ASA"-noun-0,"ASA"-tx-15-"ASA"-noun-0]|TX|3143/3;2682/3|
00000000|MMI|7.22|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AFib"-tx-31-"Afib"-noun-0,"AFib"-tx-10-"Afib"-noun-0]|TX|4033/4;2372/4|
00000000|MMI|7.16|Ambulatory Health Care Facilities; Clinic/Center; Rehabilitation: Cardiac Facilities|C1552453|[hcro,mnob]|["Cardiology clinic"-tx-40-"cardiology clinic"-noun-0,"Cardiology clinic"-tx-6-"Cardiology Clinic"-noun-0]|TX|4630/17;1586/17|
00000000|MMI|7.16|Cardiology clinic|C3810847|[hcro,mnob]|["Cardiology clinic"-tx-40-"cardiology clinic"-noun-0,"Cardiology clinic"-tx-6-"Cardiology Clinic"-noun-0]|TX|4630/17;1586/17|
00000000|MMI|7.16|Medical History|C0262926|[fndg]|["History"-tx-20-"history"-noun-1,"Hx"-tx-10-"hx"-noun-0]|TX|2934/7;2325/2|
00000000|MMI|7.11|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-53-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5162/2;52/2|
00000000|MMI|7.05|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-10-"RESUME"-noun-0,"Resume"-tx-6-"Resume"-noun-0]|TX|2249/6;1530/6|
00000000|MMI|7.05|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-10-"RESUME"-noun-0,"Resume"-tx-6-"Resume"-noun-0]|TX|2249/6;1530/6|
00000000|MMI|7.05|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-10-"RESUME"-noun-0,"resume"-tx-6-"Resume"-noun-0]|TX|2249/6;1530/6|
00000000|MMI|7.03|Clinic|C0442592|[hcro,mnob]|["Clinic"-tx-51-"Clinic"-noun-0,"Clinic"-tx-35-"clinic"-noun-0]|TX|5014/6;4287/6|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|172/4;190/4|
00000000|MMI|7.02|Good|C0205170|[qlco]|["Well"-tx-32-"well"-adv-0,"Good"-tx-24-"good"-adj-0]|TX|4085/4;3350/4|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|172/4;190/4|
00000000|MMI|7.00|+5|C0728893|[qnco]|["+5"-tx-7-"5"-fraction-0,"+5"-tx-6-"5"-integer-0]|TX|1631/1;1296/1|
00000000|MMI|7.00|>5|C0439084|[qnco]|[">5"-tx-7-"5"-fraction-0,">5"-tx-6-"5"-integer-0]|TX|1631/1;1296/1|
00000000|MMI|6.98|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-44-"Stable"-adj-0,"Stable"-tx-26-"stable"-adj-0]|TX|4763/6;3544/6|
00000000|MMI|6.98|Stable status|C0205360|[qlco]|["STABLE"-tx-44-"Stable"-adj-0,"STABLE"-tx-26-"stable"-adj-0]|TX|4763/6;3544/6|
00000000|MMI|6.97|Chemical or Textual Reference to Actual Test or Parameter|C3272558|[inpr]|["Chemical"-tx-47-"chemical"-adj-0,"Chemical"-tx-28-"chemical"-adj-0]|TX|4912/8;3735/8|
00000000|MMI|6.97|Chemicals|C0220806|[chem]|["Chemical"-tx-47-"chemical"-adj-0,"Chemical"-tx-28-"chemical"-adj-0]|TX|4912/8;3735/8|
00000000|MMI|6.95|10%|C3842590|[fndg]|["10%"-tx-6-"10"-integer-0,"10%"-tx-4-"10"-integer-0]|TX|1386/2;540/2|
00000000|MMI|6.95|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-10-"MI"-noun-0,"MI"-tx-8-"MI"-noun-0]|TX|2389/2;1727/2|
00000000|MMI|6.95|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-10-"CAD"-noun-0,"CAD"-tx-8-"CAD"-adj-0]|TX|2385/3;2007/3|
00000000|MMI|6.94|Negative - answer|C3853545|[qlco]|["Negative"-tx-21-"negative"-adj-0,"NEG"-tx-16-"neg"-noun-0]|TX|3066/8;2699/3|
00000000|MMI|6.94|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-40-"PUO"-noun-0,"puo"-tx-6-"PUO"-noun-0]|TX|4626/3;1582/3|
00000000|MMI|6.94|50%|C3842586|[fndg]|["50%"-tx-6-"50"-integer-0]|TX|[1212/2],[1438/2]|
00000000|MMI|6.94|<50|C3843766|[fndg]|["<50"-tx-6-"50"-integer-0]|TX|[1212/2],[1438/2]|
00000000|MMI|6.91|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-20-"cardiac"-adj-0,"Cardiac"-tx-10-"cardiac"-adj-0]|TX|2945/7;2427/7|
00000000|MMI|6.79|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|C20.543
00000000|MMI|6.79|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|C20.543
00000000|MMI|6.79|Radiation|C0851346|[npop]|["Radiation"-tx-12-"Radiation"-noun-0]|TX|2559/9|G01.750
00000000|MMI|6.79|Therapeutic radiology procedure|C1522449|[topp]|["RADIATION"-tx-12-"Radiation"-noun-0]|TX|2559/9|E02.815
00000000|MMI|6.71|History|C0019664|[ocdi]|["History"-tx-20-"history"-noun-0]|TX|2934/7|K01.400
00000000|MMI|6.63|Enzymes|C0014442|[enzy,orch]|["ENZYMES"-tx-16-"Enzymes"-noun-0]|TX|2691/7|D08.811
00000000|MMI|5.18|About The Same|C2346711|[qlco]|["Unchanged"-tx-16-"unchanged"-adj-0]|TX|2739/9|
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2160/10|
00000000|MMI|5.18|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|0/7|
00000000|MMI|5.18|Additional comments|C1830770|[fndg]|["Additional comments"-tx-36-"ADDITIONAL COMMENTS"-noun-0]|TX|4307/19|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|1888/9|
00000000|MMI|5.18|C-Circle|C3538933|[celc]|["CC"-tx-10-"cc"-noun-0]|TX|2276/2|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-8-"Complications"-noun-0]|TX|1872/13|
00000000|MMI|5.18|Dried Specimen|C2827485|[bdsu]|["DRIED"-tx-6-"DRIED"-verb-0]|TX|1100/5|
00000000|MMI|5.18|Dryness (characteristic)|C1512080|[qlco]|["Dried"-tx-6-"DRIED"-verb-0]|TX|1100/5|
00000000|MMI|5.18|Evening|C0587117|[tmco]|["Evening"-tx-35-"evening"-noun-0]|TX|4251/7|
00000000|MMI|5.18|Geographic state|C1301808|[geoa]|["states"-tx-11-"States"-noun-0]|TX|2463/6|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|2160/10|
00000000|MMI|5.18|Hearing Loss, Partial|C0018772|[fndg]|["hearing loss"-tx-8-"hearing loss"-noun-0]|TX|2124/12|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-8-"hypertension"-noun-0]|TX|1944/12|
00000000|MMI|5.18|Imaging Techniques|C0079595|[diap]|["Imaging"-tx-28-"imaging"-verb-0]|TX|3694/7|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-8-"PROCEDURES"-noun-0]|TX|2175/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|1888/9|
00000000|MMI|5.18|Last|C1517741|[qlco]|["Last"-tx-47-"last"-adj-0]|TX|4858/4|
00000000|MMI|5.18|Lipids|C0023779|[orch]|["Lipids"-tx-23-"lipids"-noun-0]|TX|3172/6|D10
00000000|MMI|5.18|MILDLY|C0750532|[idcn]|["MILDLY"-tx-23-"mildly"-adv-0]|TX|3184/6|
00000000|MMI|5.18|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-37-"medications"-noun-0]|TX|4342/11|
00000000|MMI|5.18|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-37-"medications"-noun-0]|TX|4342/11|
00000000|MMI|5.18|Mild (qualifier value)|C2945599|[qlco]|["Mildly"-tx-23-"mildly"-adv-0]|TX|3184/6|
00000000|MMI|5.18|No status change|C0442739|[fndg]|["Unchanged"-tx-16-"unchanged"-adj-0]|TX|2739/9|
00000000|MMI|5.18|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|71/14|
00000000|MMI|5.18|Notifications|C0422202|[hlca]|["Notify"-tx-39-"notify"-verb-0]|TX|4434/6|
00000000|MMI|5.18|Observed|C1441672|[ftcn]|["Observed"-tx-26-"observed"-verb-0]|TX|3467/8|
00000000|MMI|5.18|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|71/14|
00000000|MMI|5.18|Performed|C0884358|[ftcn]|["Performed"-tx-28-"performed"-verb-0]|TX|3705/9|
00000000|MMI|5.18|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-37-"medications"-noun-0]|TX|4342/11|D26
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-8-"PROCEDURES"-noun-0]|TX|2175/10|
00000000|MMI|5.18|Rate|C1521828|[qnco]|["Rate"-tx-32-"rate"-noun-0]|TX|4076/4|
00000000|MMI|5.18|Rating (action)|C0871208|[acty]|["Rate"-tx-32-"rate"-noun-0]|TX|4076/4|
00000000|MMI|5.18|Repeat|C0205341|[ftcn]|["Repeat"-tx-28-"repeat"-noun-0]|TX|3687/6|
00000000|MMI|5.18|Repeat Object|C1705914|[cnce]|["Repeat"-tx-28-"repeat"-noun-0]|TX|3687/6|
00000000|MMI|5.18|Repeat Pattern|C1547730|[tmco]|["Repeat"-tx-28-"repeat"-noun-0]|TX|3687/6|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-6-"("-noun-0]|TX|1575/1|
00000000|MMI|5.18|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|0/7|
00000000|MMI|5.18|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|0/7|
00000000|MMI|5.18|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-8-"NKA"-noun-0]|TX|1702/3|
00000000|MMI|5.18|Then|C1883708|[tmco]|["Then"-tx-12-"Then"-adv-0]|TX|2501/4|
00000000|MMI|5.18|Titrate|C1883350|[hlca]|["Titrate"-tx-45-"Titrate"-verb-0]|TX|4787/7|
00000000|MMI|5.18|Usage|C0457083|[ftcn]|["Use"-tx-39-"use"-verb-0]|TX|4556/3|
00000000|MMI|5.18|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-39-"use"-verb-0]|TX|4556/3|
00000000|MMI|5.18|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-5-"ATORVASTATIN"-noun-0]|TX|827/12|
00000000|MMI|5.18|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-53-"ORDERS"-verb-0]|TX|5189/6|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-6-"("-noun-0]|TX|1575/1|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-9-"TREATMENTS/PROCEDURES"-noun-0]|TX|2199/21|
00000000|MMI|5.18|warfarin dose|C0366686|[clna]|["Warfarin Dose"-tx-33-"warfarin dose"-noun-0]|TX|4148/13|
00000000|MMI|3.98|Awake|C0234422|[fndg]|["Awake"-tx-11-"awoke"-verb-0]|TX|2486/5|
00000000|MMI|3.98|Card (document)|C3275277|[inpr]|["Card"-tx-19-"CARDS"-noun-0]|TX|2841/5|
00000000|MMI|3.98|Concern|C2699424|[idcn]|["Concern"-tx-14-"Concerned"-verb-0]|TX|2634/9|
00000000|MMI|3.98|Direct (qualifier)|C1947931|[qlco]|["Direct"-tx-37-"directed"-verb-0]|TX|4357/8|
00000000|MMI|3.98|Direct type of relationship|C0439851|[qlco]|["Direct"-tx-37-"directed"-verb-0]|TX|4357/8|
00000000|MMI|3.81|aspirin enteric coated|C0718690|[orch,phsu]|["enteric coated aspirin"-tx-4-"ENTERIC COATED ASPIRIN"-noun-0]|TX|543/22|
00000000|MMI|3.75|Cardiac Imaging|C1096014|[diap]|["Cardiac Imaging"-tx-47-"cardiac imaging"-adj-0]|TX|4840/15|
00000000|MMI|3.75|Cardiac imaging methods|C0851587|[diap]|["Cardiac Imaging"-tx-47-"cardiac imaging"-adj-0]|TX|4840/15|
00000000|MMI|3.75|Imaging of heart|C2500064|[diap]|["Cardiac imaging"-tx-47-"cardiac imaging"-adj-0]|TX|4840/15|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-3-"DISCHARGE MEDICATIONS"-noun-0]|TX|213/21|
00000000|MMI|3.75|Renal dysfunction|C3279454|[fndg]|["Renal dysfunction"-tx-8-"renal dysfunction"-noun-0]|TX|2067/17|
00000000|MMI|3.75|risk factors - observation list|C1553898|[inpr]|["risk factors"-tx-20-"risk factors"-noun-0]|TX|2967/12|
00000000|MMI|3.74|ECG abnormality|C1832603|[fndg]|["EKG abnormality"-tx-16-"EKG abnormality"-noun-0]|TX|2708/3,2723/11|
00000000|MMI|3.74|Domestic activities|C0441660|[dora]|["house activity"-tx-6-"House ACTIVITY"-noun-0]|TX|1495/5,1520/8|
00000000|MMI|3.74|Gastric stent|C0940176|[fndg]|["Gastric stent"-tx-8-"gastric stent"-noun-0]|TX|1993/7,2019/5|
00000000|MMI|3.70|Cardiovascular symptoms|C0476270|[sosy]|["Heart symptoms"-tx-39-"heart symptoms"-noun-0]|TX|4529/5,4542/8|
00000000|MMI|3.68|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-39-"shortness of breath"-noun-0]|TX|4501/19|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|133/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|133/9|
00000000|MMI|3.68|Cardiologist|C0175906|[prog]|["Cardiologist"-tx-17-"cardiologist"-noun-0]|TX|2760/12|
00000000|MMI|3.68|Coating (film)|C1522408|[qlco]|["Coated"-tx-4-"COATED"-adj-0]|TX|584/6|
00000000|MMI|3.68|Enteral|C1304890|[spco]|["Enteric"-tx-4-"ENTERIC"-adj-0]|TX|576/7|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|177/6|
00000000|MMI|3.68|Worried|C0233481|[fndg]|["Worry"-tx-39-"worry"-noun-1]|TX|4419/5|
00000000|MMI|3.68|day|C0439228|[tmco]|["DAY"-tx-34-"day"-noun-0]|TX|4204/3|
00000000|MMI|3.68|per day|C0439505|[tmco]|["/day"-tx-34-"day"-noun-0]|TX|4204/3|
00000000|MMI|3.65|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1730/9,1750/9|
00000000|MMI|3.65|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1730/9,1750/9|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-51-"ENTERED"-verb-0]|TX|5094/7|
00000000|MMI|3.63|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|
00000000|MMI|3.63|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|
00000000|MMI|3.63|Control function|C2587213|[ftcn]|["Control"-tx-24-"control"-noun-0]|TX|3358/7|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|195/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|195/11|
00000000|MMI|3.63|Radiation Ionizing Radiotherapy|C1524020|[topp]|["Radiation"-tx-12-"Radiation"-noun-0]|TX|2559/9|
00000000|MMI|3.63|Radiotherapy Research|C1524021|[resa]|["Radiation"-tx-12-"Radiation"-noun-0]|TX|2559/9|
00000000|MMI|3.63|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-8-"ALLERGY"-noun-0]|TX|1693/7|
00000000|MMI|3.63|Scientific Control|C1882979|[cnce]|["Control"-tx-24-"control"-noun-0]|TX|3358/7|
00000000|MMI|3.63|True Control Status|C3274648|[qlco]|["Control"-tx-24-"control"-noun-0]|TX|3358/7|
00000000|MMI|3.63|Unit of radiation dose|C0560559|[qnco]|["Radiation"-tx-12-"Radiation"-noun-0]|TX|2559/9|
00000000|MMI|3.63|control aspects|C0243148|[qlco]|["control"-tx-24-"control"-noun-0]|TX|3358/7|
00000000|MMI|3.63|control substance|C1550141|[sbst]|["Control"-tx-24-"control"-noun-0]|TX|3358/7|
00000000|MMI|3.63|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-8-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1740/19|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-44-"PLAN"-noun-0]|TX|4776/4|
00000000|MMI|3.61|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-39-"symptoms"-noun-0]|TX|4542/8|
00000000|MMI|3.61|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-39-"symptoms"-noun-0]|TX|4542/8|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-44-"PLAN"-noun-0]|TX|4776/4|
00000000|MMI|3.61|Oral lesion|C0149744|[fndg]|["Oral lesions"-tx-48-"oral lesions"-noun-0]|TX|4954/12|
00000000|MMI|3.60|Stenting|C2348535|[topp]|["Stenting"-tx-10-"stenting"-noun-0]|TX|2400/8|
00000000|MMI|3.60|Discharge time|C3864299|[tmco]|["Discharge time"-tx-24-"time discharge"-noun-0]|TX|3285/4,3293/9|
00000000|MMI|3.60|Discharge time:ClockTime:Pt:^Patient:Qn|C3864300|[clna]|["Discharge time"-tx-24-"time discharge"-noun-0]|TX|3285/4,3293/9|
00000000|MMI|3.59|Stent Device Component|C1705817|[medd]|["Stent"-tx-8-"stent"-noun-0]|TX|2019/5|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-53-"END"-noun-0]|TX|5172/3|
00000000|MMI|3.59|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-14-"ED"-noun-0]|TX|2652/2|
00000000|MMI|3.59|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-45-"meds"-noun-0]|TX|4795/4|
00000000|MMI|3.59|Maintaining (action)|C1314677|[ftcn]|["Maintained"-tx-26-"maintained"-verb-0]|TX|3437/10|
00000000|MMI|3.59|Morning|C0332170|[tmco]|["Morning"-tx-27-"morning"-noun-0]|TX|3648/7|
00000000|MMI|3.59|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-31-"now"-adv-0]|TX|4040/3|
00000000|MMI|3.59|Reduced|C0392756|[qlco]|["Reduced"-tx-33-"reduced"-verb-0]|TX|4162/7|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-8-"Responsible"-adj-0]|TX|1761/11|
00000000|MMI|3.59|Sinus - general anatomical term|C1305231|[bsoj]|["SINUS"-tx-31-"sinus"-noun-0]|TX|4047/5|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-53-"END"-noun-0]|TX|5172/3|
00000000|MMI|3.58|Basal Diet|C2983588|[food]|["DIET"-tx-6-"DIET"-noun-0]|TX|1453/4|
00000000|MMI|3.58|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-6-"DIET"-noun-0]|TX|1453/4|
00000000|MMI|3.58|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-6-"DIET"-noun-0]|TX|1453/4|
00000000|MMI|3.58|CDISC SDTM Risk Assessment Terminology|C3539808|[inpr]|["Risk Assessment"-tx-30-"risk assessment"-noun-0]|TX|3974/15|
00000000|MMI|3.57|Patient history:-:Point in time:^Patient:-|C1369882|[clna]|["Patient Hx"-tx-31-"Patient hx"-noun-0]|TX|4005/7,4021/2|
00000000|MMI|3.57|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-51-"Held"-verb-0]|TX|5030/4|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|55/10|
00000000|MMI|3.57|Elevated|C3163633|[qlco]|["Elevated"-tx-23-"elevated"-verb-0]|TX|3191/8|
00000000|MMI|3.57|Evidence|C3887511|[idcn]|["Evidence"-tx-29-"evidence"-noun-0]|TX|3807/8|
00000000|MMI|3.57|Held - activity status|C1948036|[idcn]|["held"-tx-51-"Held"-verb-0]|TX|5030/4|
00000000|MMI|3.57|High|C0205250|[qlco]|["Elevated"-tx-23-"elevated"-verb-0]|TX|3191/8|
00000000|MMI|3.56|atenolol dose|C0366358|[clna]|["Atenolol Dose"-tx-26-"dose Atenolol"-noun-0]|TX|3505/4,3513/8|
00000000|MMI|3.56|Assessed|C1516048|[acty]|["Assess"-tx-30-"assess"-verb-0]|TX|3906/6|
00000000|MMI|3.56|Concept History|C1705255|[cnce]|["History"-tx-20-"history"-noun-0]|TX|2934/7|
00000000|MMI|3.56|HPX wt Allele|C3814444|[gngm]|["HX"-tx-10-"hx"-noun-0]|TX|2325/2|
00000000|MMI|3.56|History of present illness|C0262512|[orga]|["History, NOS"-tx-20-"history"-noun-0]|TX|2934/7|
00000000|MMI|3.56|History of previous events|C2004062|[fndg]|["History"-tx-20-"history"-noun-1]|TX|2934/7|
00000000|MMI|3.56|Possible|C0332149|[qlco]|["Possible"-tx-30-"possible"-adj-0]|TX|3917/8|
00000000|MMI|3.56|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-30-"possible"-adj-0]|TX|3917/8|
00000000|MMI|3.56|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-30-"possible"-adj-0]|TX|3917/8|
00000000|MMI|3.55|Checking (action)|C1283174|[acty]|["Check"-tx-51-"check"-noun-0]|TX|5060/5|
00000000|MMI|3.55|Cheque|C1555524|[mnob]|["Cheque"-tx-51-"check"-noun-0]|TX|5060/5|
00000000|MMI|3.55|Suspicious|C0750493|[idcn]|["Suspicious"-tx-20-"suspicious"-adj-0]|TX|2889/10|
00000000|MMI|3.55|Suspicious for Malignancy|C4050405|[fndg]|["Suspicious"-tx-20-"suspicious"-adj-1]|TX|2889/10|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|104/4|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1]|TX|91/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|91/3|
00000000|MMI|3.53|On admission|C0457453|[tmco]|["On admission"-tx-33-"On admission"-adj-0]|TX|4117/12|
00000000|MMI|3.53|One week|C4082116|[tmco]|["One week"-tx-43-"one week"-noun-0]|TX|4700/8|
00000000|MMI|3.51|Hydrochlorothiazide 12.5 MG Oral Tablet|C1358771|[clnd]|["HYDROCHLOROTHIAZIDE 12.5MG TAB"-tx-6-"HYDROCHLOROTHIAZIDE 12.5MG TAB"-noun-0]|TX|1174/26,1220/3|
00000000|MMI|3.51|Transition (action)|C2700061|[acty]|["Transition"-tx-26-"transitioned"-verb-0]|TX|3480/12|
00000000|MMI|3.51|Transition Mutation|C0599156|[comd]|["Transition"-tx-26-"transitioned"-verb-0]|TX|3480/12|
00000000|MMI|3.50|American College of Cardiology/American Heart Association Lesion Complexity Score A|C3272281|[fndg]|["Low Risk"-tx-27-"low risk"-noun-0]|TX|3588/8|
00000000|MMI|3.50|Borg Category-Ratio 10 Perceived Exertion Score 5|C4050466|[inpr]|["Severe"-tx-39-"severe"-adj-0]|TX|4461/6|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-8-"Causing"-adj-0]|TX|1789/7|
00000000|MMI|3.50|Low Risk|C3538919|[qnco]|["LOW RISK"-tx-27-"low risk"-noun-0]|TX|3588/8|
00000000|MMI|3.50|Severe (severity modifier)|C0205082|[qlco]|["SEVERE"-tx-39-"severe"-adj-0]|TX|4461/6|
00000000|MMI|3.50|Severe Extremity Pain|C4050465|[inpr]|["Severe"-tx-39-"severe"-adj-0]|TX|4461/6|
00000000|MMI|3.50|Well|C3146287|[mnob]|["Well"-tx-32-"well"-adv-0]|TX|4085/4|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|129/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|129/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-51-"dictated"-adj-0]|TX|5077/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-51-"dictated"-adj-0]|TX|5077/8|
00000000|MMI|3.48|30%|C3842588|[fndg]|["30%"-tx-6-"30"-integer-0]|TX|1321/2|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|
00000000|MMI|3.48|ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS|C3540048|[enzy,phsu]|["ENZYMES"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|C3540772|[enzy,phsu]|["Enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Enzymes for ALIMENTARY TRACT AND METABOLISM|C3542456|[enzy,phsu]|["Enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Enzymes, antithrombotic|C3541394|[enzy,phsu]|["Enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Enzymes, hematological|C3540017|[enzy,phsu]|["Enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Enzymes, peripheral vasodilators|C3540790|[enzy,phsu]|["Enzymes"-tx-16-"Enzymes"-noun-0]|TX|2691/7|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-3-"Full"-adj-0]|TX|185/4|
00000000|MMI|3.48|N not otherwise specified Antibody|C0369718|[aapp,imft]|["N NOS"-tx-12-"N"-noun-0]|TX|2555/1|
00000000|MMI|3.48|N+ (tumor staging)|C0441922|[inpr]|["N+"-tx-12-"N"-noun-0]|TX|2555/1|
00000000|MMI|3.48|Out (direction)|C0439787|[spco]|["Out"-tx-12-"out"-adv-0]|TX|2545/3|
00000000|MMI|3.48|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-10-"p"-adj-0]|TX|2455/1|
00000000|MMI|3.48|P prime|C2603361|[clna]|["P'"-tx-10-"p"-adj-0]|TX|2455/1|
00000000|MMI|3.48|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-6-"regular exercise"-noun-0]|TX|1537/16|
00000000|MMI|3.48|Removed|C0849355|[qlco]|["Out"-tx-12-"out"-adv-0]|TX|2545/3|
00000000|MMI|3.48|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|E02
00000000|MMI|3.48|Treating|C1522326|[ftcn]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-8-"Treatment"-noun-0]|TX|1898/9|
00000000|MMI|3.48|chronic|C0205191|[tmco]|["CHRONIC"-tx-8-"chronic"-adj-0]|TX|2059/7|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-8-"Treatment"-noun-0]|TX|1898/9|
00000000|MMI|3.47|mg/mg|C1319635|[qnco]|["mg/mg"-tx-6-"MG MG"-noun-0]|TX|1417/2,1441/2|
00000000|MMI|3.47|Attack behavior|C1261512|[socb]|["attack"-tx-39-"attack"-noun-0]|TX|4535/6|
00000000|MMI|3.47|Capsule Dosing Unit|C1706433|[qnco]|["{Capsule}"-tx-3-"CAPSULE"-noun-0]|TX|274/7|
00000000|MMI|3.47|Capsule Shape|C1704652|[qlco]|["CAPSULE"-tx-3-"CAPSULE"-noun-0]|TX|274/7|
00000000|MMI|3.47|Extreme|C0205403|[qlco]|["Extremely"-tx-27-"extremely"-adv-0]|TX|3578/9|
00000000|MMI|3.47|Microbial anatomical capsule structure|C1325531|[celc]|["capsule"-tx-3-"CAPSULE"-noun-0]|TX|274/7|
00000000|MMI|3.47|Observation of attack|C1304680|[fndg]|["Attack"-tx-39-"attack"-noun-0]|TX|4535/6|
00000000|MMI|3.47|Onset of illness|C0277793|[tmco]|["Attack"-tx-39-"attack"-noun-0]|TX|4535/6|
00000000|MMI|3.46|Oral infection|C0555971|[dsyn]|["Oral infection"-tx-43-"oral infection"-noun-0]|TX|4726/14|
00000000|MMI|3.46|stress study|C0809864|[diap]|["Stress study"-tx-28-"stress study"-noun-0]|TX|3744/12|
00000000|MMI|3.46|Atypical|C0205182|[qlco]|["Atypical"-tx-20-"atypical"-adj-0]|TX|2984/8|
00000000|MMI|3.46|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-16-"bs"-noun-0]|TX|2715/2|
00000000|MMI|3.46|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-16-"bs"-noun-0]|TX|2715/2|
00000000|MMI|3.46|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-16-"bs"-noun-0]|TX|2715/2|
00000000|MMI|3.46|Intravascular line|C0700221|[medd]|["Line"-tx-16-"line"-noun-0]|TX|2718/4|
00000000|MMI|3.46|Line Specimen|C1550648|[sbst]|["Line"-tx-16-"line"-noun-0]|TX|2718/4|
00000000|MMI|3.46|Line Unit of Length|C1552960|[qnco]|["Line"-tx-16-"line"-noun-0]|TX|2718/4|
00000000|MMI|3.46|Linear|C0205132|[spco]|["Line"-tx-16-"line"-noun-0]|TX|2718/4|
00000000|MMI|3.46|atypia morphology|C0741302|[fndg]|["Atypical"-tx-20-"atypical"-adj-0]|TX|2984/8|
00000000|MMI|3.46|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-6-"ADA"-noun-0]|TX|1503/3|
00000000|MMI|3.46|CA8 gene|C1413051|[gngm]|["CALS"-tx-6-"cals"-noun-0]|TX|1512/4|
00000000|MMI|3.46|Genus Ada|C1060325|[plnt]|["Ada"-tx-6-"ADA"-noun-0]|TX|1503/3|
00000000|MMI|3.46|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-6-"cals"-noun-0]|TX|1512/4|
00000000|MMI|3.46|Primary|C0205225|[qlco]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|1730/9|
00000000|MMI|3.46|Study Day|C2826182|[tmco]|["DY"-tx-6-"dy"-noun-0]|TX|1517/2|
00000000|MMI|3.46|Teaching principal|C0401925|[prog]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|1730/9|
00000000|MMI|3.46|kilocalorie|C0439259|[qnco]|["Cal"-tx-6-"cals"-noun-0]|TX|1512/4|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-6-"chol"-noun-0]|TX|1471/4|
00000000|MMI|3.45|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-6-"sat"-noun-0]|TX|1480/3|
00000000|MMI|3.45|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-6-"sat"-noun-0]|TX|1480/3|
00000000|MMI|3.45|Ulceration|C3887532|[patf]|["ULCER"-tx-8-"ulcer"-noun-0]|TX|2001/5|
00000000|MMI|3.45|Carbohydrates|C0007004|[orch]|["Sugar"-tx-6-"SUGAR"-adj-0]|TX|1106/5|D09
00000000|MMI|3.45|Empty (qualifier)|C1880497|[qlco]|["Free"-tx-6-"FREE"-adj-0]|TX|1112/4|
00000000|MMI|3.45|Free (available (qualifier))|C1996904|[qlco]|["Free"-tx-6-"FREE"-adj-0]|TX|1112/4|
00000000|MMI|3.45|Free of (attribute)|C0332296|[ftcn]|["free"-tx-6-"FREE"-adj-0]|TX|1112/4|
00000000|MMI|3.45|RAW SUGAR|C3665462|[bodm,orch]|["sugar"-tx-6-"SUGAR"-adj-0]|TX|1106/5|
00000000|MMI|3.45|Sugars|C0242209|[orch,phsu]|["SUGAR"-tx-6-"SUGAR"-adj-0]|TX|1106/5|D09
00000000|MMI|3.45|cardiac event|C0741923|[dsyn]|["cardiac event"-tx-20-"cardiac event"-noun-1]|TX|2912/13|
00000000|MMI|3.45|Unit|C0439148|[qnco]|["UNITS"-tx-6-"UNITS"-noun-0]|TX|1389/5|
00000000|MMI|3.45|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-6-"UNITS"-noun-0]|TX|1389/5|
00000000|MMI|3.45|Unit of Measure|C1519795|[qnco]|["Units"-tx-6-"UNITS"-noun-0]|TX|1389/5|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|9/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|9/3|
00000000|MMI|3.44|Event Seriousness - Significant|C1546944|[qlco]|["Significant"-tx-29-"significant"-adj-0]|TX|3819/11|
00000000|MMI|3.44|Maxillary right third molar mesial prosthesis|C1552211|[medd]|["1pm"-tx-7-"1PM"-noun-0]|TX|1624/3|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|9/3|
00000000|MMI|3.44|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-39-"pain"-noun-0]|TX|4396/4|
00000000|MMI|3.44|Poor - grade value|C0542537|[qlco]|["Poor"-tx-10-"poor"-adj-0]|TX|2422/4|
00000000|MMI|3.44|Poor - qualifier|C2700379|[qlco]|["Poor"-tx-10-"poor"-adj-0]|TX|2422/4|
00000000|MMI|3.44|Significant|C0750502|[idcn]|["Significant"-tx-29-"significant"-adj-0]|TX|3819/11|
00000000|MMI|3.44|Statistical Significance|C0237881|[qnco]|["significant"-tx-29-"significant"-adj-0]|TX|3819/11|
00000000|MMI|3.44|Weekly|C0332174|[tmco]|["/week"-tx-8-"week"-noun-0]|TX|1672/4|
00000000|MMI|3.44|week|C0439230|[tmco]|["WEEK"-tx-8-"week"-noun-0]|TX|1672/4|
00000000|MMI|3.43|/40|C0439509|[tmco]|["/40"-tx-25-"40's"-noun-0]|TX|3394/4|
00000000|MMI|3.43|40%|C3842587|[qnco]|["40%"-tx-25-"40's"-noun-0]|TX|3394/4|
00000000|MMI|3.43|Associated with|C0332281|[qlco]|["Associated"-tx-39-"associated"-adj-0]|TX|4487/10|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-10-"BRIEF"-adj-0]|TX|2243/5|
00000000|MMI|3.43|Brief|C1879313|[tmco]|["Brief"-tx-10-"BRIEF"-adj-0]|TX|2243/5|
00000000|MMI|3.43|During values|C0347985|[tmco]|["Peri"-tx-48-"Peri"-adj-0]|TX|4949/4|
00000000|MMI|3.43|Infrequent|C0521114|[tmco]|["Occasional"-tx-39-"occasional"-adj-0]|TX|4571/10|
00000000|MMI|3.43|Shortened|C1282927|[qlco]|["brief"-tx-10-"BRIEF"-adj-0]|TX|2243/5|
00000000|MMI|3.43|teams|C0871489|[grup]|["Team"-tx-17-"team"-noun-0]|TX|2805/4|
00000000|MMI|3.43|Abnormality|C1704258|[fndg]|["Abnormality"-tx-29-"abnormality"-noun-0]|TX|3845/11|
00000000|MMI|3.43|Current (present ti